Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumor (vol 51, 102566, 2020)

被引：0
|
作者：
Xu, Yi-Wei
机构：
来源：
EBIOMEDICINE | 2021年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 37 条
  • [21] Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis
    Li, Chuling
    Lv, Yanling
    Shao, Chenye
    Chen, Cen
    Zhang, Tianli
    Wei, Yuqing
    Fan, Hang
    Lv, Tangfeng
    Liu, Hongbin
    Song, Yong
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 20721 - 20727
  • [22] GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer (vol 37, pg 2652, 2017)
    Ouyang, Fei
    Liu, Junling
    Xia, Meng
    Lin, Chuyong
    Wu, Xianqiu
    Ye, Liping
    Song, Libing
    Li, Jun
    Wang, Jing
    Guo, Peng
    He, Mian
    ONCOLOGY REPORTS, 2021, 45 (05)
  • [23] RETRACTED: Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification (Retracted Article)
    Liu, Xiaofeng
    Chen, Wenyan
    Qi, Yu
    Zhu, Yongqian
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [24] Significant Elevation of Oxidized DJ-1 in Erythrocytes of Early-Stage Parkinson Disease Patients: Potential Application of Oxidized DJ-1 Levels for Diagnosis of PD at Early Stage
    Saito, Yoshiro
    Hamakuba, Takao
    Yoshida, Yasukazu
    Akazawa, Yoko Ogawa
    Shichiri, Mototado
    Noguchi, Noriko
    Niki, Etsuo
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 : S80 - S80
  • [25] Serum miR152 as a novel prognostic biomarker and potential tumor suppressor for early stage non-small cell lung cancer
    Oba, Taro
    Ye, Yuanqing
    Zhang, Liren
    Lin, Jing
    Gentile, Emanuela
    Wang, Jing
    Zhao, Yang
    Gu, Jiang
    Wistuba, Ignacio
    Roth, Jack A.
    Wu, Xifeng
    Ji, Lin
    CANCER RESEARCH, 2016, 76
  • [26] Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease
    Heng-Hong Li
    Kathryn Doiron
    Andrew D Patterson
    Frank J Gonzalez
    Albert J Fornace Jr
    Journal of Translational Medicine, 11
  • [27] Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease
    Li, Heng-Hong
    Doiron, Kathryn
    Patterson, Andrew D.
    Gonzalez, Frank J.
    Fornace, Albert J., Jr.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [28] Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis (vol 15, e0235990, 2020)
    Gao, J.
    Chen, B.
    Lin, H.
    Liu, Y.
    Wei, Y.
    Chen, F.
    PLOS ONE, 2021, 16 (02):
  • [29] KRAS-regulated P4HA1 in pancreatic tumor and its hydroxylated peptide as a serum biomarker for early diagnosis
    Deng, Zaian
    Mann, Karen M.
    Koay, Eugene J.
    Ferrari, Mauro
    Wu, Xifeng
    Chiao, Paul J.
    Hu, Tony
    CANCER RESEARCH, 2015, 75
  • [30] Assessment of the progression of vertical semicircular canal dysfunction and increased vestibular endolymphatic hydrops in patients with early-stage Meniere disease (vol 146, pg 1, 2020)
    Fukushima, M.
    Ueno, Y.
    Kitayama, I
    Akahani, S.
    Inohara, H.
    Takeda, N.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2020, 146 (09) : 876 - 876
1234